← Leaderboards
Gil Dan Rabinovici
Indiana University Indianapolis
$42,270,973
Attributed
$166,639,515
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $50M · FY2008–25$50M$37.5M$25M$12.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$186,664,453 · 13
By mechanism
U01$130,662,749 · 2
P30$26,038,337 · 3
R56$13,719,545 · 2
R01$9,430,599 · 2
R35$4,816,964 · 1
K23$793,428 · 1
Top collaborators
- Bradford C Dickerson11 shared
- Liana G Apostolova9 shared
- Maria C Carrillo9 shared
- Katherine Laurel Possin5 shared
- Michael Alosco4 shared
- Monica G Rivera-Mindt3 shared
- Tatiana M. Foroud2 shared
- Sterling C Johnson2 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Bradford C Dickerson$59,157,479
- Liana G Apostolova$29,240,655
- Maria C Carrillo$19,827,813
- Laura Cracco$670,029
- Benjamin Ryskeldi-Falcon$670,029
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseDementiaBiological MarkersDiagnosisTau ProteinsAmyloidPositron-Emission TomographyNerve DegenerationMagnetic Resonance ImagingImageCognitiveNeuroimagingPhenotypeAmyloid Beta-ProteinResourcesClinical PhenotypeSymptomsBrainGeneticSyndromePathologyDiagnosticInnovation
Grant awards (46)
New Approaches to Dementia Heterogeneity$4,684,291
P30 · FY2025 · AG · contact PI
Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II$3,019,032
R01 · FY2025 · NS
Core A - Administrative Core$1,458,163
P30 · FY2025 · AG · contact PI
Reimagining Precision Medicine Approaches to AD Diagnosis$944,809
R35 · FY2025 · AG · contact PI
ADRC Consortium for Clarity in ADRD Research Through Imaging$29,557,545
U01 · FY2024 · AG
New Approaches to Dementia Heterogeneity$4,673,112
P30 · FY2024 · AG · contact PI
Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II$3,289,394
R01 · FY2024 · NS
Core A - Administrative Core$974,087
P30 · FY2024 · AG · contact PI
Reimagining Precision Medicine Approaches to AD Diagnosis$964,640
R35 · FY2024 · AG · contact PI
ADRC Consortium for Clarity in ADRD Research Through Imaging$30,800,018
U01 · FY2023 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$13,904,119
U01 · FY2023 · AG
New Approaches to Dementia Heterogeneity$3,461,380
P30 · FY2023 · AG · contact PI
Reimagining Precision Medicine Approaches to AD Diagnosis$964,092
R35 · FY2023 · AG · contact PI
Core A: Administrative Core$837,229
P30 · FY2023 · AG · contact PI
Biomarker Evaluation in Young Onset Dementia from Diverse Populations (BEYONDD)$6,065,228
R56 · FY2022 · AG
New Approaches to Dementia Heterogeneity$3,461,380
P30 · FY2022 · AG · contact PI
Core A: Administrative Core$968,944
P30 · FY2022 · AG · contact PI
Reimagining Precision Medicine Approaches to AD Diagnosis$964,042
R35 · FY2022 · AG · contact PI
In Vivo Detection of Chronic Traumatic Encephalopathy with 18F-MK-6240 Tau PET$202,733
R21 · FY2022 · NS · contact PI
Early Onset AD Consortium - the LEAD Study (LEADS)$16,618,207
U01 · FY2021 · AG
New Approaches to Dementia Heterogeneity$3,744,775
P30 · FY2021 · AG · contact PI
Core A: Administrative Core$1,774,976
P30 · FY2021 · AG · contact PI
Early Onset AD Consortium - the LEAD Study (LEADS)$1,072,053
U01 · FY2021 · AG
Reimagining Precision Medicine Approaches to AD Diagnosis$979,381
R35 · FY2021 · AG · contact PI
In Vivo Detection of Chronic Traumatic Encephalopathy with 18F-MK-6240 Tau PET$258,483
R21 · FY2021 · NS · contact PI
Early Onset AD Consortium - the LEAD Study (LEADS)$15,954,813
U01 · FY2020 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$11,820,016
U01 · FY2019 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$2,473,288
U01 · FY2019 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$176,937
U01 · FY2019 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$8,285,753
U01 · FY2018 · AG
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration$612,045
R01 · FY2018 · AG · contact PI
Project 1: Early-Onset Alzheimers Disease: Imaging and Genetic Phenotypes$151,328
P50 · FY2018 · AG · contact PI
Early Onset Alzheimer's Disease Consortium$7,654,317
R56 · FY2017 · AG
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration$617,005
R01 · FY2017 · AG · contact PI
Project 1: Early-Onset Alzheimers Disease: Imaging and Genetic Phenotypes$151,276
P50 · FY2017 · AG · contact PI
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration$623,504
R01 · FY2016 · AG · contact PI
Project 1: Early-Onset Alzheimers Disease: Imaging and Genetic Phenotypes$148,530
P50 · FY2016 · AG · contact PI
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration$608,110
R01 · FY2015 · AG · contact PI
Project 1: Early-Onset Alzheimers Disease: Imaging and Genetic Phenotypes$143,360
P50 · FY2015 · AG · contact PI
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration$661,509
R01 · FY2014 · AG · contact PI
Project 1: Early-Onset Alzheimers Disease: Imaging and Genetic Phenotypes$147,121
P50 · FY2014 · AG · contact PI
Amyloid PET in AD, FTLD & PPA: Diagnosis, Functional & Structural Correlations$159,402
K23 · FY2012 · AG · contact PI
Amyloid PET in AD, FTLD & PPA: Diagnosis, Functional & Structural Correlations$159,402
K23 · FY2011 · AG · contact PI
Amyloid PET in AD, FTLD & PPA: Diagnosis, Functional & Structural Correlations$159,294
K23 · FY2010 · AG · contact PI
Amyloid PET in AD, FTLD & PPA: Diagnosis, Functional & Structural Correlations$157,549
K23 · FY2009 · AG · contact PI
Amyloid PET in AD, FTLD & PPA: Diagnosis, Functional & Structural Correlations$157,781
K23 · FY2008 · AG · contact PI